首页|Graphene oxide-graphene Van der Waals heterostructure transistor biosensor for SARS-CoV-2 protein detection
Graphene oxide-graphene Van der Waals heterostructure transistor biosensor for SARS-CoV-2 protein detection
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NSTL
Elsevier
The current outbreaking of the coronavirus SARS-CoV-2 pandemic threatens global health and has caused serious concern. Currently there is no specific drug against SARS-CoV-2, therefore, a fast and accurate diagnosis method is an urgent need for the diagnosis, timely treatment and infection control of COVID-19 pandemic. In this work, we developed a field effect transistor (FET) biosensor based on graphene oxide-graphene (GO/Gr) van der Waals heterostructure for selective and ultrasensitive SARS-CoV-2 proteins detection. The GO/Gr van der Waals heterostructure was in-situ formed in the microfluidic channel through 7C-7C stacking. The developed biosensor is capable of SARS-CoV-2 proteins detection within 20 min in the large dynamic range from 10 fg/mL to 100 pg/mL with the limit of detection of as low as -8 fg/mL, which shows -3 x sensitivity enhancement compared with GrFET biosensor. The performance enhancement mechanism was studied based on the transistor-based biosensing theory and experimental results, which is mainly attributed to the enhanced SARS-CoV-2 capture antibody immobilization density due to the introduction of the GO layer on the graphene surface. The spiked SARS-CoV-2 protein samples in throat swab buffer solution were tested to confirm the practical application of the biosensor for SARS-CoV-2 proteins detection. The results indicated that the developed GO/Gr van der Waals heterostructure FET biosensor has strong selectivity and high sensitivity, providing a potential method for SARS-CoV-2 fast and accurate detection.
Van der waals heterostructureSARS-CoV-2Protein detectionGraphene field-effect transistorHYSTERESIS
NSTL
Elsevier
